首页> 外文期刊>Journal of Cancer Research and Therapeutics >Nodal ratio of positive to excised nodes, but not number of positive lymph nodes is better to predict group to avoid chemotherapy among postmenopausal ER-positive, lymph node-positive T1-T2 breast cancer patients
【24h】

Nodal ratio of positive to excised nodes, but not number of positive lymph nodes is better to predict group to avoid chemotherapy among postmenopausal ER-positive, lymph node-positive T1-T2 breast cancer patients

机译:绝经后ER阳性,淋巴结阳性的T1-T2乳腺癌患者中,淋巴结阳性与切除的淋巴结比率较好,但淋巴结阳性的数目没有更好地预测该组避免化疗

获取原文
       

摘要

Aim of Study: To identify whether nodal ratio (NR) of positive to excised nodes is superior to number of positive lymph nodes to predict group to avoid chemotherapy among postmenopausal ER-positive, lymph node-positive, T1-T2 breast cancer patients. Materials and Methods: Postmenopausal estrogen receptor (ER)-positive, lymph node-positive patients who received endocrine therapy (n = 173) with complete baseline data in our hospital between 2000 and 2006 were included. The disease-free survival (DFS) was compared. Survival analysis was performed using Kaplan-Meier method. Cox proportional hazard models were used to evaluate the prognostic value of chemotherapy with different NR for DFS. P - values less than 0.05 were regarded as significant. Results: The median follow-up was 72 months. Three of 13 variables analyzed remained significantly prognostic for survival in the Cox proportional hazards model. These included age (hazard ratio (HR) =1.642, 95% confidence interval (CI) =1.154-2.337, P = 0.006); histological grade (HR = 2.463,95% CI = 1.389-4.367, P = 0.002); and NR (HR = 2.280, 95% CI = 1.113-4.671, P = 0.024). Subgroup analysis by NR status showed that in patients with NR ≥ 0.20, chemotherapy significantly improves DFS (HR = 0.360, 95% CI = 0.195-0.663, P = 0.001); while in patients with NR Conclusion: This retrospective analysis demonstrates that NR of positive to excised nodes, but not number of positive lymph nodes is better to predict group to avoid chemotherapy among postmenopausal ER-positive, lymph node-positive T1-T2 breast cancer patients.
机译:研究目的:为了确定绝经后ER阳性,淋巴结阳性,T1-T2乳腺癌患者中淋巴结阳性率(NR)是否优于淋巴结阳性率,以预测组避免化疗。材料与方法:纳入绝经后雌激素受体(ER)阳性,淋巴结阳性的患者,这些患者在2000年至2006年间在我院接受了完整的基线数据的内分泌治疗(n = 173)。比较无病生存期(DFS)。使用Kaplan-Meier方法进行生存分析。 Cox比例风险模型用于评估不同NR对DFS化疗的预后价值。小于0.05的P值被认为是显着的。结果:中位随访72个月。在Cox比例风险模型中,分析的13个变量中的3个仍对生存率具有明显的预后。其中包括年龄(危险比(HR)= 1.642,95%置信区间(CI)= 1.154-2.337,P = 0.006);组织学分级(HR = 2.463,95%CI = 1.389-4.367,P = 0.002);和NR(HR = 2.280,95%CI = 1.113-4.671,P = 0.024)。通过NR状态进行的亚组分析显示,NR≥0.20的患者,化疗可显着改善DFS(HR = 0.360,95%CI = 0.195-0.663,P = 0.001);结论:这项回顾性分析表明,绝经后ER阳性,淋巴结阳性的T1-T2乳腺癌患者中,淋巴结阳性至切除淋巴结的NR,但不是淋巴结阳性的数目更好地预测了避免化疗的组。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号